Artificial Intelligence (AI) in Neurology Operating Room Market is expected to grow at a CAGR of 49.69% by 2030

AI in Neurology Operating Room

BIS Research defines AI in neurology operating room as a sub-segment of the overall healthcare system wherein algorithms, software, and AI-enabled devices are used for augmenting the neurosurgical process, data management, diagnosis, and rehabilitation, among other operations which are limited to the operation theater.

The impact on AI adoption in operating rooms was low-moderate due to the fact that the global AI in neurology operating room market is in the early stage of commercialization and has been witnessing strong growth in terms of market value.

The global artificial intelligence (AI) in neurology operating room market is expected to grow at a CAGR of 49.69% during the forecast period, 2021-2030.

Many players in the global AI in operating room market have products and solutions which cater to applications such as scheduling, diagnosis, training, and instrument tracking for most of the indications. However, with time, new market entrants are expected to target niche applications and indications. Given the nature and the early phase of developments in the market, many companies have products in the pipeline, and more new players can be continuing their research and development in stealth mode.

The global AI in neurology operating room market is expected to witness tremendous growth during the forecast period 2021-2030, registering a CAGR of XX%. Leading companies in the market aim to maintain a competitive advantage with a strong global presence and advanced product portfolio.

The concept of artificial intelligence in the operating room is not a new concept. However, products have been commercialized only since 2018. Thus, most of the companies in the market have been involved in funding activities in recent years.

AI-based software used in operating rooms is rigorously trained by using numerous datasets and images that are then used for various applications, including identification of image patterns, improvement of workflow, image analysis, decision support, remote monitoring, predictive analysis, and reporting and communication.

The purpose of the study is to enable the reader to gain a holistic view of the global AI in neurology operating room market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global AI in neurology operating room market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers software solutions and hardware solutions integrated with AI.

Request a Sample - https://bisresearch.com/requestsample?id=1118&type=download

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog